Skip to content
Screener

AngioDynamics ANGO United States — Net Sales

Similar metrics at other companies

Lowe's Companies logo
LOWUnited States — Net Sales
$23.01B+9.9%
Dick's Sporting Goods logo
DKSUnited States — Net Sales
$4.63B+45.9%
Medtronic logo
MDTUnited States — Net Sales
$4.87B+7.1%
OLP
OLPXUnited States — Net Sales
$47.44M-3.5%
TTC
TTCUnited States — Net Sales
$1.15B+7.9%
Thor Industries logo
THOUnited States — Net Sales
$1.53B-1.1%

Other financials

Income statement

See full
Revenue$86.6M+8.0%
Gross profit$46.8M+10.8%
Operating income-$10.2M-76.1%
Net income-$11.4M-88.5%
EPS (diluted)-$0.27-80.0%

Balance sheet

See full
Cash & equivalents$53.9M-3.6%
Total debt$11.0M+8.0%
Total equity$170.8M-6.6%
Total assets$267.2M-4.6%

Cash flow

See full
Operating cash flow$17.5M
CapEx$413.0K-46.8%
Free cash flow$17.0M

Valuation

See full
Market cap$648.51M+88.9%
Enterprise value$605.6M+103%
P/S+0.9×

Profitability

See full
Gross margin54.6%+0.7pp
Operating margin-12.5%-1.0pp
Net margin-11.5%-0.1pp
FCF margin0.2%

Returns & leverage

See full
Return on equity-20.8%+4.8pp
Debt / equity0.1×0.0×
Current ratio2.2×0.0×

Where this comes from

Reported directly by AngioDynamics in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The source filing: AngioDynamics’s 10-K, filed July 14, 2026.

Filed
Jul 14, 2026, 3:42 PM EDT
Fiscal year
FY2026
Accession
0001628280-26-048138
(in thousands)Year ended May 31, 2026 / United StatesYear ended May 31, 2026 / InternationalYear ended May 31, 2026 / TotalYear ended May 31, 2025 / United StatesYear ended May 31, 2025 / InternationalYear ended May 31, 2025 / Total
Net sales
Med Tech$129,830$20,124$149,954$109,254$17,399$126,653
Med Device145,09325,127170,220141,72924,116165,845
Total$274,923$45,251$320,174$250,983$41,515$292,498

Item 15. Exhibits, Financial Statement Schedules.

FAQ

What is AngioDynamics's united states — net sales?
AngioDynamics (ANGO) reported united states — net sales of $73.6M in Q1 2026.
How has AngioDynamics's united states — net sales changed year-over-year?
AngioDynamics's united states — net sales increased by 9.1% year-over-year, from $67.48M to $73.6M.
What is the long-term trend for AngioDynamics's united states — net sales?
Over 4 years (2022 to 2026), AngioDynamics's united states — net sales has grown at a 0.8% compound annual growth rate (CAGR), from $265.96M to $274.92M.
What does united states — net sales mean?
This metric represents the total revenue generated from the sale of medical devices and therapeutic solutions within the domestic market. It serves as a primary indicator of the company's market penetration and commercial performance in its largest geographic region. Tracking this figure helps investors assess the stability and growth trajectory of the core business operations in the United States.

Ask your AI about AngioDynamics's united states — net sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude